A case control study on risk factors involved in inflammatory breast recurrence after breast-conserving surgery

Oncology

Volumn 55, Issue 5, 1998, Pages 391-399

  Nishimura, Reiki ^a   Koyama, Hiroki ^b   Kasumi, Fujio ^c   Takashima, Shigemitsu ^d   Kobayashi, Shunzo ^e   Komaki, Kansei ^f   Ohkawa, Tomohiko ^g   Shin, Eisei ^h   Kodama, Hiroshi ⁱ   Fukutomi, Takashi ^j   Nishi, Tsunehiro ^k   Sonoo, Hiroshi ^l   Sano, Sohmei ^m   Kimishima, Izo ⁿ   Nakaue, Kazuhiko ^o   Nakamura, Seigo ^p   Kusama, Mikihiro ^q   Okumura, Kenzo ^r  

^a KUMAMOTO CITY HOSPITAL   (Japan)

^b OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

^c CANCER INSTITUTE HOSPITAL   (Japan)

^d NATIONAL HOSPITAL ORGANIZATION SHIKOKU CANCER CENTER   (Japan)

^e NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

^f UNIVERSITY OF TOKUSHIMA   (Japan)

^g TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^h OSAKA NATIONAL HOSPITAL   (Japan)

ⁱ Kodama Clinic   (Japan)

^j NATIONAL CANCER CENTER HOSPITAL   (Japan)

^k MITSUI MEMORIAL HOSPITAL   (Japan)

^l KAWASAKI MEDICAL SCHOOL   (Japan)

^m NIIGATA CANCER CENTER HOSPITAL   (Japan)

ⁿ FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^o Shizuoka Pref General Hospital   (Japan)

^p ST LUKE'S INTERNATIONAL HOSPITAL   (Japan)

^q TOKYO MEDICAL UNIVERSITY   (Japan)

^r NATIONAL HOSPITAL ORGANIZATION KURE MEDICAL CENTER AND CHUGOKU CANCER CENTER   (Japan)

more..

Author keywords

Breast recurrence, inflammatory; Breast conserving surgery

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; CANCER RECURRENCE; CONSERVATIVE TREATMENT; CONTROLLED STUDY; EMBOLISM; FEMALE; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; LYMPH VESSEL; LYMPHANGITIS; MAJOR CLINICAL STUDY; MASTITIS; PATHOLOGY; PRIORITY JOURNAL; RISK FACTOR;

EID: 0031854567     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000011884     Document Type: Article

References (25)

1. Schnitt SJ, Connolly JL, Harris JR, et al: Pathological predictors of early local recurrence in stage I and II breast cancer related by primary radiation therapy. Cancer 1984;53: 1049-1057.
2. Tominaga T, Ishii T: Prognostic factors of inflammatory breast cancer (in Japanese with English abstract). Jpn J Breast Cancer 1992;7: 29-35.
3. Glass JL, Frazee RC: Inflammatory breast cancer. Am Surg 1995;61:121-124.
4. Espie M, Extra JM, Roquancourt A, et al: Inflammatory cancer of the breast: Review and experience at Saint-Louis Hospital. Arch Anat Cytol Pathol 1995;43:36-43.
5. Pisansky TM, Schaid DJ, Loprinzi CL, et al: Inflammatory breast cancer: Integration of irradiation, surgery and chemotherapy. Am J Clin Oncol 1992;15:376-387.
6. Donegan WL, Padrta B: Combined therapy for inflammatory breast cancer. Arch Surg 1990; 125:578-582.
7. Thomas F, Arriagata R, Spielmann M, et al: Pattern of failure in patients with inflammatory breast cancer treated by alternating radiation therapy and chemotherapy. Cancer 1995; 76:2286-2290.
8. Saltzstein SI: Clinically occult inflammatory carcinoma of the breast. Cancer 1974;34:382-388.
9. Rosen PP: Inflammatory carcinoma; in Harris JR, Hellman S, Henderson IC, Kinne DW (eds): Breast Disease, ed 2. Philadelphia, Lippincott, 1991, pp 278-279.
10. Watanabe K: Pathological basis of inflammatory breast carcinoma (in Japanese with English abstract). Jpn J Breast Cancer 1992;7:5-16.
11. Paradiso A, Tommasi S, Brandi M, et al: Cell kinetics and hormonal receptor status in inflammatory breast carcinoma, comparison with locally advanced disease. Cancer 1989;64: 1922-1927.
12. Bonnier P, Charpin C, Lejeune C, et al: Inflammatory carcinomas of the breast: A clinical and pathological definition? Int J Cancer 1995;62: 382-385.
13. Fisher ER, Sass R, Fisher B, et al: Pathologic findings from the National Surgical Breast Project (protocol 6): II. Relation of local breast recurrence to multicentricity. Cancer 1986;57: 1717-1724.
14. Kurtz JM, Jacquemier J, Brandone H, et al: Inoperable recurrence after breast-conserving surgical treatment and radiotherapy. Surg Obstet Gynecol 1991;172:357-361.
15. Clarke DH, Monique G, Sarrazin D, et al: Analysis of local-regional relapses in patients with early breast cancers treated by excision and radiotherapy: Experience of the institute Gustave-Roussy. Int J Radiat Oncol Biol Phys 1985;11:137-145.
16. Osborne MP, Borgen PI, Wong GY, et al: Salvage mastectomy for local and regional recurrence after breast-conserving operation and radiation therapy. Surg Obstet Gynecol 1992; 174:189-194.
17. Haffty BG, Goldberg NB, Fischer D, et al: Conservative surgery and radiation therapy in breast carcinoma: Local recurrence and prognostic implications. Int J Radiat Oncol Biol Phys 1989;17:727-732.
18. Perez CA, Fields JN, Fracasso PM, et al: Management of locally advanced carcinoma of the breast. II. Inflammatory carcinoma. Cancer 1994;74:466-476.
19. Bauer RL, Busch E, Levine E, et al: Therapy for inflammatory breast cancer: Impact of doxorubicin-based therapy. Ann Surg Oncol 1995;2: 288-294.
20. Chavallier B, Roche H, Olivier JP, et al: Inflammatory breast cancer. Pilot study of intensive induction chemotherapy (FEC-HD) results in a high histologic response rate. Am J Clin Oncol 1993;16:223-228.
21. Jaiyesimi IA, Buzdar AU, Hortobagyi G: Inflammatory breast cancer: A review. J Clin Oncol 1992;10:1014-1024.
22. Noguchi S, Koyama H, Motomura K, et al: Management of inflammatory breast carcinoma of the breast with combined modality therapy (in Japanese with English abstract). Jpn J Breast Cancer 1992;7:36-44.
23. Gradishar WJ: Inflammatory breast cancer: The evolution of multimodality treatment strategies. Semin Surg Oncol 1996;12:352-363.
24. Levine PH, Steinhorn SC, Ries LE, et al: Inflammatory breast cancer: The experience of the Surveillance Epidemiology and End Results (SEER) Program. J Natl Cancer Inst 1985; 74:291-297.
25. Fields JN, Kuske RR, Perez CA, et al: Inflammatory carcinoma of the breast: Treatment results on 107 patients. Int J Radiat Oncol Biol Phys 1989;17:249-255.